Introduction In Canada, deceased organ donation provides over 80% of transplanted organs. At the time of death, families, friends or others assume responsibility as substitute decision-makers (SDMs) to consent to organ donation. Despite their central role in this process, little is known about what barriers, enablers and beliefs influence decision-making among SDMs. This study aims to explore the experiences and perspectives of SDMs involved in making decisions around the withdrawal of life-sustaining therapies, end-of-life care and deceased organ donation.
Methods and analysis SDMs of 60 patients admitted to intensive care units will be enrolled for this study. Ten hospitals across five provinces in Canada in a prospective multicentre qualitative cohort study. We will conduct semistructured telephone interviews in English or French with SDMs between 6 and 8 weeks after the patient’s death. Our sampling frame will stratify SDMs into three groups: SDMs who were not approached for organ donation; SDMs who were approached and consented to donate and SDMs who were approached but did not consent to donate. We will use two complementary theoretical frameworks—the Common-Sense Self-Regulation Model and the Theoretical Domains Framework— to inform our interview guide. Interview data will be analysed using deductive directed content analysis and inductive thematic analysis.
Ethics and dissemination This study has been approved by the Centre Hospitalier de l’Université de Montréal Research Ethics Board. The findings from this study will help identify key factors affecting substitute decision-making in deceased organ donation, reasons for non-consent and barriers to achieve congruency between SDM and patient wishes. Ultimately, these data will contribute to the development and evaluation of tools and training for healthcare providers to support SDMs in making decisions about organ donation.
Trial registration number NCT03850847.
- intensive and critical care
- qualitative research
- quality in health care
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Twitter @JakeECrawshaw, @Ball, @DrSimonKitto
Collaborators The Canadian Critical Care Trials Group and the Canadian Donation and Transplantation Research Program
Contributors All authors (JC, JP, ZvA, LPC, KJ, SE, DAF, FL, AFT, AJS, CM, FD, AHL, GK, IB, JB, KEAB, MCF, MW, MM, PM, SS, SZ, SD, SCK, MC) participated in conceiving this study. The conduct of the study will be led by MC, JP and KJ. All authors provided input into the protocol, critical feedback on the manuscript, and approved the final manuscript.
Funding This study is supported by the Canadian Institute of Health Research, grant number PJT-155997. MC, FL, FDA and MCF are recipients of a salary support award from the Fonds de Recherche Québec – Santé (FRQS). AFT is the chair holder of the Canada Research Chair in Critical Care Neurology and Trauma.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval A prospective multicentre qualitative cohort study has been approved by the Centre Hospitalier de l’Université de Montréal Research Ethics Board (MP-02-2019-7792). Provincial and local ethics approval will also be obtained from each participating site.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.